Investing in the Covid-19 vaccine companies? Here’s the great divide in the group

Some have a robust pipeline of drugs that uses new technology. And others may be left behind.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.